Spencer C. Fleischer - Jun 30, 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 04:20 PM
Previous filing
May 26, 2021
Next filing
Jul 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $0 +170 +21.96% $0.00 944 Jun 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +57.6 +0.61% $0.00 9.56K May 7, 2021 Common Stock 57.6 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of receipt of director's fees pursuant to the Independent Directors' Stock-Based Compensation Plan.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.